| CP-MGAH22-05 | A Phase 1b/2, Open Label, Dose Escalation Study of Margetuximab in Combination with Pembrolizumab in Patients with Relapsed/Refractory Advanced HER2+ Gastroesophageal Junction or Gastric Cancer | Juergens, Dr Rosalyn | Open | NCT02689284 |
| HE.1 | A PHASE III STUDY OF PALLIATIVE RADIOTHERAPY FOR SYMPTOMATIC HEPATOCELLULAR CARCINOMA AND LIVER METASTASES | Wong, Dr Raimond | Open | NCT02511522 |
| KEYNOTE 240 | A Phase III Study of Pembrolizumab (MK-3475) vs. Best Supportive Care as Second-Line Therapy in Subjects with Previously Systemically Treated Advanced Hepatocellular Carcinoma (KEYNOTE-240) | Zbuk, Dr Kevin | Open | NCT02702401 |
| OZM-067 | A Prospective Single-Arm, Multi-Centre, Study of the Efficacy and Safety of Lutetium-177 Octreotate (Lu-DOTATATE) Treatment with individualized dosimetry in Patients with 68Ga-DOTATATE identified Somatostatin Receptor Positive Neuroendocrine Tumors | Juergens, Dr Rosalyn | Open | NCT02743741 |
| PA.7 | A Randomized Phase II Trial of Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma | Goffin, Dr John | Open | NCT02879318 |
| PERIOP-01 | A Multicentre Randomized Controlled Trial of the Use of Extended Peri-Operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colorectal Cancer | Simunovic, Dr Marko | Open | NCT01455831 |
| RTOG 1112 | Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer | Swaminath, Dr Anand | Open | NCT01730937 |
| CO.21 | A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE) | Goffin, Dr John | On hold | NCT00819208 |
Find a Trial
Contact Us